Ribosomopathies: New Therapeutic Perspectives.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
11 09 2020
Historique:
received: 31 07 2020
revised: 03 09 2020
accepted: 08 09 2020
entrez: 16 9 2020
pubmed: 17 9 2020
medline: 21 4 2021
Statut: epublish

Résumé

Ribosomopathies are a group of rare diseases in which genetic mutations cause defects in either ribosome biogenesis or function, given specific phenotypes. Ribosomal proteins, and multiple other factors that are necessary for ribosome biogenesis (rRNA processing, assembly of subunits, export to cytoplasm), can be affected in ribosomopathies. Despite the need for ribosomes in all cell types, these diseases result mainly in tissue-specific impairments. Depending on the type of ribosomopathy and its pathogenicity, there are many potential therapeutic targets. The present manuscript will review our knowledge of ribosomopathies, discuss current treatments, and introduce the new therapeutic perspectives based on recent research. Diamond-Blackfan anemia, currently treated with blood transfusion prior to steroids, could be managed with a range of new compounds, acting mainly on anemia, such as L-leucine. Treacher Collins syndrome could be managed by various treatments, but it has recently been shown that proteasomal inhibition by MG132 or Bortezomib may improve cranial skeleton malformations. Developmental defects resulting from ribosomopathies could be also treated pharmacologically after birth. It might thus be possible to treat certain ribosomopathies without using multiple treatments such as surgery and transplants. Ribosomopathies remain an open field in the search for new therapeutic approaches based on our recent understanding of the role of ribosomes and progress in gene therapy for curing genetic disorders.

Identifiants

pubmed: 32932838
pii: cells9092080
doi: 10.3390/cells9092080
pmc: PMC7564184
pii:
doi:

Substances chimiques

Ribosomal Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

Sci Rep. 2017 Jul 25;7(1):6440
pubmed: 28743979
Science. 2017 Nov 3;358(6363):
pubmed: 29097519
J Pediatr Endocrinol Metab. 2004 Jan;17(1):47-54
pubmed: 14960021
Plast Reconstr Surg. 2016 Jan;137(1):191-204
pubmed: 26710023
Mol Ther. 2017 Aug 2;25(8):1805-1814
pubmed: 28434866
Ann N Y Acad Sci. 2011 Dec;1242:40-55
pubmed: 22191555
Nat Rev Genet. 2018 Jul;19(7):431-452
pubmed: 29725087
Pediatr Int. 2013 Dec;55(6):e162-4
pubmed: 24330304
Br J Haematol. 1998 Dec;103(4):990-6
pubmed: 9886310
Blood. 2012 Sep 13;120(11):2214-24
pubmed: 22734070
Cancer Res. 2010 Jul 15;70(14):6026-35
pubmed: 20587522
Trends Neurosci. 2016 May;39(5):290-299
pubmed: 27032601
J Pediatr. 2002 Aug;141(2):266-70
pubmed: 12183725
Mol Psychiatry. 2006 Dec;11(12):1073-84
pubmed: 16940977
Nature. 2015 Apr 30;520(7549):640-5
pubmed: 25901680
Rare Dis. 2015 Apr 01;3(1):e1025185
pubmed: 26442198
Nat Genet. 1999 Feb;21(2):169-75
pubmed: 9988267
Br J Cancer. 2012 Nov 20;107(11):1844-52
pubmed: 23169337
N Engl J Med. 1961 May 11;264:953-67
pubmed: 13750594
Nucleic Acids Res. 2020 Jan 24;48(2):770-787
pubmed: 31799629
Genet Med. 2016 Jan;18(1):49-56
pubmed: 25790162
Genomics. 1994 Apr;20(3):347-53
pubmed: 8034306
Hum Mutat. 2012 Jul;33(7):1037-44
pubmed: 22431104
Nat Genet. 2011 Jan;43(1):20-2
pubmed: 21131976
Am J Med Genet A. 2007 Nov 15;143A(22):2675-81
pubmed: 17937437
Am J Med Genet A. 2003 Jul 30;120A(3):423-8
pubmed: 12838567
Case Rep Hematol. 2019 Jul 1;2019:4684156
pubmed: 31355022
Eur J Pediatr. 1993 Mar;152(3):211-7
pubmed: 8444246
Blood. 2011 Dec 22;118(26):6943-51
pubmed: 22045982
RNA. 2017 Apr;23(4):466-472
pubmed: 28053271
Clin Genet. 2020 Jan;97(1):89-102
pubmed: 31231794
Lancet Psychiatry. 2017 Apr;4(4):339-346
pubmed: 27979720
Pediatr Hematol Oncol. 1994 Jul-Aug;11(4):423-6
pubmed: 7947015
Nat Rev Cancer. 2018 Jan;18(1):51-63
pubmed: 29192214
Blood. 2009 Sep 10;114(11):2236-43
pubmed: 19561322
J Med Genet. 2017 Aug;54(8):558-566
pubmed: 28331068
J Med Genet. 1992 Sep;29(9):652-5
pubmed: 1404295
Nature. 2001 Sep 27;413(6854):432-5
pubmed: 11574891
Hum Genet. 2013 Nov;132(11):1265-74
pubmed: 23812780
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15960-4
pubmed: 16247010
Am J Hum Genet. 2006 Dec;79(6):1110-8
pubmed: 17186470
Br J Haematol. 2011 Nov;155(3):308-17
pubmed: 21988145
Blood. 2012 Sep 13;120(11):2225-8
pubmed: 22791294
Hum Mol Genet. 1998 Nov;7(12):1947-52
pubmed: 9811939
Curr Opin Cell Biol. 1997 Jun;9(3):337-42
pubmed: 9159079
Am J Hum Genet. 2017 Mar 2;100(3):506-522
pubmed: 28257692
Hum Mol Genet. 2016 Dec 15;25(24):5353-5364
pubmed: 27798105
Curr Gene Ther. 2018;18(6):327-335
pubmed: 30411682
Best Pract Res Clin Haematol. 2013 Dec;26(4):365-75
pubmed: 24507813
Hum Mutat. 2007 Dec;28(12):1178-82
pubmed: 17647292
Am J Hum Genet. 2008 Dec;83(6):769-80
pubmed: 19061985
Nat Rev Mol Cell Biol. 2018 Dec;19(12):791-807
pubmed: 30038383
Curr Opin Cell Biol. 2002 Jun;14(3):319-27
pubmed: 12067654
Sci Rep. 2018 Nov 16;8(1):17227
pubmed: 30442972
Hum Mol Genet. 1996;5 Spec No:1391-6
pubmed: 8875242
Turk J Pediatr. 2019;61(3):407-412
pubmed: 31916719
Blood Cells Mol Dis. 2007 Jul-Aug;39(1):35-43
pubmed: 17376718
Genetics. 2014 Oct;198(2):723-33
pubmed: 25316788
Int J Mol Sci. 2019 May 21;20(10):
pubmed: 31117293
Oncogene. 2013 Feb 28;32(9):1110-20
pubmed: 22525275
Hum Mol Genet. 1998 Oct;7(11):1795-800
pubmed: 9736782
Blood. 2002 Oct 15;100(8):2724-31
pubmed: 12351378
Leukemia. 2019 Jun;33(6):1303-1312
pubmed: 30962581
Br J Haematol. 2013 Sep;162(6):854-6
pubmed: 23782100
Cancer Discov. 2017 Oct;7(10):1069-1087
pubmed: 28923911
Hum Mol Genet. 2008 May 1;17(9):1253-63
pubmed: 18230666
Leuk Lymphoma. 2012 Feb;53(2):218-24
pubmed: 21827374
J Bone Miner Res. 2019 Nov;34(11):2101-2116
pubmed: 31237961
Dis Model Mech. 2015 Sep;8(9):1013-26
pubmed: 26398160
Neurology. 2014 Apr 15;82(15):1322-30
pubmed: 24647030
Trends Genet. 2019 Oct;35(10):754-767
pubmed: 31376929
J Pediatr. 2011 Jan;158(1):142-8, 148.e1
pubmed: 20846672
Haematologica. 2014 Dec;99(12):1792-8
pubmed: 25216681
Cell Death Dis. 2016 Oct 6;7(10):e2397
pubmed: 27711076
Hum Mutat. 2013 Dec;34(12):1698-707
pubmed: 24115260
Nat Rev Cancer. 2019 Apr;19(4):228-238
pubmed: 30670820
Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13403-8
pubmed: 16938878
Cancer Res. 2010 Jun 1;70(11):4767-77
pubmed: 20501855
Nat Genet. 2003 Jan;33(1):97-101
pubmed: 12496757
Biomolecules. 2019 Nov 07;9(11):
pubmed: 31703473
Genes Dev. 2011 May 1;25(9):917-29
pubmed: 21536732
Sci Transl Med. 2017 Feb 8;9(376):
pubmed: 28179501
Biochem Pharmacol. 2019 May;163:362-370
pubmed: 30849304
Hum Mol Genet. 2018 Feb 15;27(4):691-705
pubmed: 29300972
Cells. 2019 Mar 11;8(3):
pubmed: 30862070
Nat Med. 2014 Apr;20(4):398-407
pubmed: 24658077
Clin Genet. 2008 Feb;73(2):103-12
pubmed: 18005359
Am J Hum Genet. 2016 Jul 7;99(1):115-24
pubmed: 27346687
Br J Haematol. 2014 May;165(3):349-57
pubmed: 24666134
Cell. 2017 Dec 14;171(7):1599-1610.e14
pubmed: 29245012
J Clin Invest. 2012 Jul;122(7):2439-43
pubmed: 22706301
Cell. 2001 Jan 26;104(2):195-203
pubmed: 11207361
Biochem Biophys Res Commun. 2009 Aug 21;386(2):396-401
pubmed: 19527688
Science. 2013 May 24;340(6135):976-8
pubmed: 23579497
J Clin Invest. 2017 Nov 1;127(11):4090-4103
pubmed: 28972538
Blood. 2008 Sep 1;112(5):1582-92
pubmed: 18535205
N Engl J Med. 2012 Jul 5;367(1):11-9
pubmed: 22762314
Hear Res. 2020 Sep 1;394:107958
pubmed: 32334889
Haematologica. 2019 Jun;104(6):1112-1123
pubmed: 31073079
Am J Hematol. 2018 Aug;93(4):527-536
pubmed: 29285795
PLoS Genet. 2014 May 29;10(5):e1004371
pubmed: 24875531
Hematology Am Soc Hematol Educ Program. 2006;:192-8
pubmed: 17124060
J Neurochem. 2019 Feb;148(3):325-347
pubmed: 30144322
Haematologica. 2012 Dec;97(12):1813-7
pubmed: 22689679
Bone Marrow Transplant. 2006 Dec;38(11):751-6
pubmed: 17041608
J Clin Oncol. 1996 Apr;14(4):1320-6
pubmed: 8648390
Mol Cell Biol. 2018 May 29;38(12):
pubmed: 29610153
Blood. 2007 Feb 1;109(3):980-6
pubmed: 16990592
Hematol Oncol Clin North Am. 2018 Aug;32(4):669-685
pubmed: 30047419
Cell Rep. 2017 Oct 24;21(4):953-965
pubmed: 29069603
Biomolecules. 2018 Oct 24;8(4):
pubmed: 30356013
Br J Haematol. 2008 Sep;142(6):859-76
pubmed: 18671700
J Pharm Biomed Anal. 2012 Dec;71:228-32
pubmed: 22944355
Protein Sci. 2016 Aug;25(8):1390-406
pubmed: 27198711
Blood. 2015 Aug 13;126(7):880-90
pubmed: 26109203
Curr Opin Struct Biol. 2018 Apr;49:85-93
pubmed: 29414516
Blood Cells Mol Dis. 2005 May-Jun;34(3):257-63
pubmed: 15885610
Blood. 2012 Mar 8;119(10):2376-84
pubmed: 22262766
Pediatr Blood Cancer. 2006 May 1;46(5):558-64
pubmed: 16317735
Expert Rev Hematol. 2019 Dec;12(12):1037-1052
pubmed: 31478401
Am J Hum Genet. 2010 Feb 12;86(2):222-8
pubmed: 20116044
Nat Genet. 1998 May;19(1):6-7
pubmed: 9590276
J Clin Invest. 2019 Jun 18;129(9):3821-3826
pubmed: 31211692
Mol Cell. 2017 Jul 6;67(1):71-83.e7
pubmed: 28625553
Cancer. 2012 Jan 15;118(2):418-27
pubmed: 21717444
Hum Mutat. 2015 Dec;36(12):1155-8
pubmed: 26290468
Am J Hum Genet. 2019 Nov 7;105(5):1040-1047
pubmed: 31630789
Nature. 2008 Jan 17;451(7176):335-9
pubmed: 18202658
Blood. 2007 Feb 1;109(3):1275-83
pubmed: 17053056
J Pediatr Gastroenterol Nutr. 2000 Oct;31(4):395-404
pubmed: 11045837
Nat Struct Mol Biol. 2015 Nov;22(11):914-9
pubmed: 26479198
Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16127-32
pubmed: 24043769
Cell. 2018 Mar 22;173(1):90-103.e19
pubmed: 29551269
Pediatr Res. 1999 Nov;46(5):553-61
pubmed: 10541318
Am J Hum Genet. 2018 Dec 6;103(6):930-947
pubmed: 30503522
J Med Genet. 2017 Jun;54(6):417-425
pubmed: 28280134
J Pediatr Hematol Oncol. 2004 Jun;26(6):379-81
pubmed: 15167352
Science. 2018 Oct 5;362(6410):86-91
pubmed: 30166439
Am J Hum Genet. 2017 Aug 3;101(2):267-273
pubmed: 28777933
N Engl J Med. 2016 May 19;374(20):1922-31
pubmed: 27192671
Mol Cell. 2019 Jan 3;73(1):36-47.e10
pubmed: 30503772
Am J Hum Genet. 2002 Dec;71(6):1443-9
pubmed: 12417987
Science. 2006 May 12;312(5775):902-6
pubmed: 16690864

Auteurs

Emilien Orgebin (E)

INSERM, Bone sarcomas and remodeling of calcified tissues, Nantes Université, UMR 1238, F-44000 Nantes, France.

François Lamoureux (F)

INSERM, Bone sarcomas and remodeling of calcified tissues, Nantes Université, UMR 1238, F-44000 Nantes, France.

Bertrand Isidor (B)

CHU Nantes, Service de Génétique Médicale, F-44000 Nantes, France.

Céline Charrier (C)

INSERM, Bone sarcomas and remodeling of calcified tissues, Nantes Université, UMR 1238, F-44000 Nantes, France.

Benjamin Ory (B)

INSERM, Bone sarcomas and remodeling of calcified tissues, Nantes Université, UMR 1238, F-44000 Nantes, France.

Frédéric Lézot (F)

INSERM, Bone sarcomas and remodeling of calcified tissues, Nantes Université, UMR 1238, F-44000 Nantes, France.

Marc Baud'huin (M)

INSERM, Bone sarcomas and remodeling of calcified tissues, Nantes Université, UMR 1238, F-44000 Nantes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH